Barely Significant
← all excerpts

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.

Cancers (Basel) · 2022 · PMC9139619 · PMID 35626170

1
hedged sentence
closest p
boldest claim

The sentences

a clear trendno p-value reported
Important analyzing the six samples for metabolic and apoptotic values we found a positive correlation between apoptosis and glycolytic levels in the AML blast treated with both the ascorbate and ascorbate–buformin treatments (Pearson’s coefficient r = 0.7) ( p = 0.1) ( Figure 5 d); even if these results are not significant, which would probably be due to the low number of samples, there is a clear trend in line with our previous results. 3.8.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.